75 related articles for article (PubMed ID: 8266818)
1. Inhibition of tumor necrosis factor-alpha secretion by pentoxifylline in advanced cancer patients with abnormally high blood levels of tumor necrosis factor-alpha.
Lissoni P; Ardizzoia A; Perego MS; Grassi MG; Arosio M; D'Amico P; Cazzaniga M; Crispino S; Tancini G; Barni S
J Biol Regul Homeost Agents; 1993; 7(2):73-5. PubMed ID: 8266818
[TBL] [Abstract][Full Text] [Related]
2. Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatonin.
Lissoni P; Barni S; Tancini G; Brivio F; Tisi E; Zubelewicz B; Braczkowski R
J Biol Regul Homeost Agents; 1994; 8(4):126-9. PubMed ID: 7660855
[TBL] [Abstract][Full Text] [Related]
3. Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis.
Selim K; Hüseyin C; Ibrahim KH; Hasan BU; Kazim U; Hüseyin K
Med J Malaysia; 2004 Aug; 59(3):391-4. PubMed ID: 15727386
[TBL] [Abstract][Full Text] [Related]
4. Study of pentoxifylline induced modulation of TNF alpha and interleukin-6 secretion in healthy and septic patients by the use of an ex-vivo model on whole blood.
Bienvenu J; Coulon L; Barbier Y; Barbier M; Doche C; Lepape A; Guenounou M
Nouv Rev Fr Hematol (1978); 1992; 34 Suppl():S65-7. PubMed ID: 1340532
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease.
Ardizzoia A; Lissoni P; Brivio F; Tisi E; Perego MS; Grassi MG; Pittalis S; Crispino S; Barni S; Tancini G
J Biol Regul Homeost Agents; 1992; 6(3):103-7. PubMed ID: 1492596
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II study of pentoxifylline with zidovudine on HIV-1 growth in AIDS patients.
Luke DR; McCreedy BJ; Sarnoski TP; Bookout JB; Johnston AM; Lell JE; Wiggan EB; Bell N; Limjuco RA; Guthrie KI
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):343-50. PubMed ID: 8370633
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
de Moura FJ; Leal PP; de Souza Furtado R; Muniz-Junqueira MI; Veiga JP
Toxicology; 2008 Jan; 243(1-2):66-74. PubMed ID: 18022309
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
[TBL] [Abstract][Full Text] [Related]
9. The effects of oral pentoxifylline on the cytokine release syndrome during inductive OKT3.
DeVault GA; Kohan DE; Nelson EW; Holman JM
Transplantation; 1994 Feb; 57(4):532-40. PubMed ID: 8116037
[TBL] [Abstract][Full Text] [Related]
10. The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study.
el-Darouti M; Marzouk S; Abdel Hay R; el-Tawdy A; Fawzy M; Leheta T; Gammaz H; Al Gendy N
Br J Dermatol; 2009 Aug; 161(2):313-9. PubMed ID: 19466963
[TBL] [Abstract][Full Text] [Related]
11. Transient increase of plasma interleukin-6 after infusion of recombinant tumor necrosis factor alpha in advanced cancer patients.
Zubelewicz B; Romanowski W; Braczkowska B; Lissoni P; Braczkowski R
J Exp Clin Cancer Res; 1998 Dec; 17(4):449-52. PubMed ID: 10089067
[TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties.
Fantin M; Quintieri L; Kúsz E; Kis E; Glavinas H; Floreani M; Padrini R; Duda E; Vizler C
Eur J Pharmacol; 2006 Mar; 535(1-3):301-9. PubMed ID: 16545799
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281
[TBL] [Abstract][Full Text] [Related]
14. Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock.
Lechner AJ; Rouben LR; Potthoff LH; Tredway TL; Matuschak GM
Circ Shock; 1993 Apr; 39(4):306-15. PubMed ID: 8485822
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha-induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes is partially mediated by prostaglandins.
Arias-Díaz J; Vara E; García C; Balibrea JL
J Clin Invest; 1994 Jul; 94(1):244-50. PubMed ID: 8040266
[TBL] [Abstract][Full Text] [Related]
16. Possible biological indicators of the response to recombinant tumour necrosis factor alpha in patients with advanced neoplasms.
Braczkowski R; Zubelewicz B; Romanowski W; Lissoni P; Brivio F
J Exp Clin Cancer Res; 1998 Sep; 17(3):349-54. PubMed ID: 9894774
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer-induced immunosuppression: relationship to tumor necrosis factor-alpha (TNF-alpha) release from ovarian tissue.
Hassan MI; Kassim SK; Saeda L; Laban M; Khalifa A
Anticancer Res; 1999; 19(6C):5657-62. PubMed ID: 10697636
[TBL] [Abstract][Full Text] [Related]
19. [Immunomodulatory effect of pentoxifylline in Graves ophthalmopathy].
Balázs C; Kiss E; Vámos A; Molnár I; Farid NR
Orv Hetil; 1997 Nov; 138(45):2869-74. PubMed ID: 9432636
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis.
Satapathy SK; Garg S; Chauhan R; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
Am J Gastroenterol; 2004 Oct; 99(10):1946-52. PubMed ID: 15447754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
